Dr John Montgomery Griffin Jr, PHD | |
16404 Smokey Point Blvd, Suite 208, Arlington, WA 98223-8417 | |
(360) 651-0610 | |
(360) 651-0656 |
Full Name | Dr John Montgomery Griffin Jr |
---|---|
Gender | Male |
Speciality | Psychologist - Clinical |
Location | 16404 Smokey Point Blvd, Arlington, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861440844 | NPI | - | NPPES |
483531 | Other | WA | VALUE OPTIONS |
0198265 | Other | WA | DEPT OFLABOR & INDUSTRIES |
297445100000 | Other | WA | PREMARA BLUE CROSS |
417158 | Other | WA | DEPARTMENT OF DISABILITIE |
2497GR | Other | WA | REGENCE BLUE SHIELD |
7049695 | Medicaid | WA | |
8913453 | Other | WA | CRIME VICTIMS COMPENSATIO |
0005893652 | Other | WA | AETNA PIN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 1564 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John Montgomery Griffin Jr, PHD 16404 Smokey Point Blvd, Suite 208, Arlington, WA 98223-8417 Ph: (360) 651-0610 | Dr John Montgomery Griffin Jr, PHD 16404 Smokey Point Blvd, Suite 208, Arlington, WA 98223-8417 Ph: (360) 651-0610 |
News Archive
Described as a way to improve the nation's prosperity, the Obama administration announced a sweeping plan to emphasize health promotion and disease prevention for all walks of life.
CASI Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that China's Food and Drug Administration has approved the Company's application to conduct a Phase II clinical trial in triple-negative breast cancer (TNBC) patients in China for its proprietary drug candidate, ENMD-2076.
Children's Hospital Los Angeles has been named one of the nation's "Most Wired" hospitals by Health & Health Networks magazine. The magazine measures the level of health information technology (IT) adoption annually in U.S. hospitals and health systems through an annual survey process.
Media outlets analyze the data on premiums for 36 states released this week by the Obama administration - looking at the impact of competition on prices and assessing which regions - and which consumers - might be winners or losers in the new online marketplaces.
DV Biologics LLC announced today that it has executed an agreement with System Biosciences LLC for the development of human-derived disease-specific induced pluripotent stem cell lines.
› Verified 3 days ago
Ms. Ellen Soukup, MS, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 17825 59th Ave Ne Ste B, Arlington, WA 98223 Phone: 360-363-4234 Fax: 360-363-4235 |